About Neonatal Jaundice

Overview
Neonatal jaundice, also known as neonatal hyperbilirubinemia, is a condition characterized by yellowing of the skin and whites of the eyes in newborns. It occurs when there is an accumulation of bilirubin, a yellow pigment produced during the breakdown of red blood cells, in the bloodstream. In healthy individuals, the liver processes and eliminates bilirubin; however, in newborns, the liver may not be fully developed, leading to elevated levels of bilirubin in the blood. Neonatal jaundice is a common condition that affects up to 60% of newborns and typically develops within the first week of life. While most cases of neonatal jaundice are harmless and resolve on their own, high levels of bilirubin can potentially cause neurological damage if left untreated.
Causes and Risk Factors

Neonatal jaundice can have both physiological and pathological causes. Physiological jaundice, which is harmless, occurs due to the normal breakdown of red blood cells in newborns. Pathological jaundice, on the other hand, can be caused by various factors such as:

  • Blood group incompatibility (most commonly ABO incompatibility)
  • Hemolysis (breakdown of red blood cells)
  • Infection (sepsis)
  • Liver disease
  • Metabolic disorders
  • Deficiency of the enzyme glucose-6-phosphate-dehydrogenase

Non-modifiable risk factors for neonatal jaundice cannot be changed or controlled. These include:

  • Maternal diseases during pregnancy, such as syphilis and leiomyoma
  • Maternal history of salpingo-oophoritis before pregnancy

Modifiable risk factors for neonatal jaundice can be influenced or changed. These include:

  • Infection and inflammatory diseases
  • Dyspepsia

It's important to note that these risk factors may vary depending on individual circumstances, and it's always best to consult with a healthcare professional for personalized advice.

Symptoms

The most common early symptoms of Neonatal Jaundice include:

  • Yellow or orange-tinted face, whites of the eyes, and gums
  • Mild difficulty sleeping or being woken up
  • Reduced urine production or dark-colored urine
  • Trouble breastfeeding, suckling a bottle, or eating
  • Mild fussiness and difficult to soothe

As Neonatal Jaundice progresses or becomes more severe, the following symptoms may occur:

  • Stiff, limp, or floppy body
  • High-pitched, continual crying
  • Strange or uncoordinated eye movements
  • Body arching like a bow, with the head, neck, and heels bent backward and the rest of the body angled forward
  • Seizures
  • Bulging of the soft spot on the top of a baby's head

It is important to seek immediate medical attention if you suspect symptoms of severe jaundice or kernicterus. Remember to consult with your healthcare professional for an accurate diagnosis and appropriate treatment.

Diagnosis

To diagnose Neonatal Jaundice, the following examinations, tests, and procedures are commonly performed:

  • Bilirubin blood test: This test measures the levels of bilirubin in the baby's blood.
  • Complete blood count (CBC): This test helps determine if the jaundice is due to an underlying condition by checking the baby's blood count and blood type.
  • Coombs test: This test checks for antibodies that indicate an increased risk of red cell breakdown.

To determine the stage or severity of Neonatal Jaundice, additional examinations, tests, and procedures may be performed:

  • Liver function tests: These blood tests measure specific proteins and enzymes produced by the liver to assess its health.
  • Imaging studies: Abdominal ultrasounds or CT scans may be used to generate images of the internal organs, including the liver.
  • Liver biopsies: Small samples of liver tissue may be removed for microscopic examination to further evaluate the condition.

It's important to consult with a healthcare professional for a proper diagnosis and to determine the appropriate examinations and tests for your baby.

Treatment Options

The goals of treatment for Neonatal Jaundice include:

  • Reducing high levels of bilirubin: The main aim of treatment is to lower the level of bilirubin in the baby's blood to prevent neurological damage. This can be achieved through various interventions.
  • Preventing kernicterus: Kernicterus is a severe form of brain damage caused by high levels of bilirubin. Treatment aims to prevent this condition by managing and reducing bilirubin levels.

Treatment options for Neonatal Jaundice include:

  • Phototherapy: This is the most common treatment for jaundice. It involves exposing the baby's skin to special lights that help break down bilirubin into a form that can be excreted from the body. Phototherapy is believed to be safe and effective in reducing bilirubin levels.
  • Exchange transfusion: In severe cases, when phototherapy alone is not sufficient, exchange transfusion may be necessary. This procedure involves replacing a small amount of the baby's blood with donor blood, which helps remove excess bilirubin from the body.

Other treatments or interventions recommended for Neonatal Jaundice include:

  • Close monitoring: Regular monitoring of bilirubin levels is essential to ensure timely intervention if levels become too high.
  • Supportive care: Providing a supportive environment for the baby, including maintaining hydration and ensuring proper nutrition, is important for overall well-being.
  • Skin-to-skin contact and maternal communication: Maintaining contact between mother and baby, even during treatment, can help promote bonding and reduce the risk of hospital-acquired infections.
  • Massage therapy: Massage has been suggested as a non-invasive and supplementary treatment for jaundiced babies, although further research is needed to establish its effectiveness.

A healthcare professional can provide the best guidance on treatment options based on the baby's individual situation.

Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Other side effects can occur. Check with your health care professional or read the information provided with your medication for additional side effect information.